PharmatrophiX
PrivateLast Round
Grant
Jan 5, 2016
Total Funding Raised
$2.58M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PharmatrophiX operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in January 2016.
PharmatrophiX is a clinical-stage biopharmaceutical company that develops disease-modifying small molecule drugs targeting mechanisms underlying neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmatrophiX Comparables
Compare PharmatrophiX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allyx Therapeutics, Inc. | 83% | |
| Gismo Therapeutics | 82% | |
| Spinogenix, Inc. | 81% |
For institutional investors. Book with your work email.
PharmatrophiX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 5, 2016 | ||||
| VC Round | Oct 6, 2014 | ||||
| Grant | Jul 1, 2013 | ||||
| Debt | Aug 29, 2012 | ||||
| Grant | Oct 1, 2009 | ||||
Grant | Feb 1, 2008 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PharmatrophiX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | VC Round |
| S-Cubed Capital | VC Round |
| Piedmont Capital Investments | VC Round |
| Alzheimer's Association | Grant |
| Alzheimer's Drug Discovery Foundation | VC Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 76% MoM.
- Jul 26, 2026
Monthly visitors grew 34% MoM.
For institutional investors. Book with your work email.
PharmatrophiX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PharmatrophiX's valuation, stock price, and market status.
Is PharmatrophiX a public or private company?
PharmatrophiX is a private company.
What is the current stock price of PharmatrophiX?
PharmatrophiX is a private company, so its shares have no public market price. Caplight tracks PharmatrophiX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PharmatrophiX worth (valuation)?
Valuation information for PharmatrophiX is not publicly available.
Can I buy PharmatrophiX stock?
PharmatrophiX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PharmatrophiX's last funding round?
PharmatrophiX's most recent funding round was Grant on January 5, 2016.
Who are the main investors in PharmatrophiX?
Key investors in PharmatrophiX include Dolby Family Ventures, Alzheimer's Drug Discovery Foundation.
Will PharmatrophiX IPO soon?
No public IPO plans have been announced for PharmatrophiX.
How can I track PharmatrophiX secondary market activity?
Caplight tracks bids, offers, and trades in PharmatrophiX's shares on secondary markets.